ONC Beone Medicines Ltd.

$270.25 +2.83%

Healthcare · Pharmaceutical Preparations

Beone Medicines Ltd. (ONC) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $390.6 billion. Shares last traded at $270.25, 29.8% below their 52-week high. Over the past year the stock is up 6.3%. ONC trades at a price-to-earnings ratio of 1361.26, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 5.4%, above the peer median of -0.1%. Revenue grew 40.2% year over year.

Market Cap

$390.6B

Shares Out

1.45B

EPS (TTM)

$0.37

P/E Ratio

730.42

P/S Ratio

73.10

P/B Ratio

82.05

Dividend / Share

—

Dividend Yield

—

52-Week High

$385.24

52-Week Low

$239.38

Volume

22,143

Avg Vol (3m)

17,338.365

Performance

+3.82%

-9.01%

-4.46%

-11.21%

YTD

-13.11%

+6.30%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

41.17

SMA (50)

$295.53

SMA (200)

$318.38

Price vs SMA50

-8.55%

Price vs SMA200

-15.12%

ATR (14)

$7.75

Financials

Revenue

$5.3B

Net Income

$287M

Gross Margin

87.5%

Operating Margin

8.4%

Net Margin

5.4%

Return on Equity

6.0%

Return on Assets

3.4%

Current Ratio

3.64

Debt / Equity

0.18

Revenue Growth (YoY)

+40.2%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.15	2026-05-06
FY 2025	$0.19	2026-02-26
Q3 2025	$0.15	2025-11-06
Q2 2025	$0.07	2025-08-06
Q1 2026	$0.00	2026-05-06
FY 2025	$-0.47	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

ONC vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

1361.26 / 16.82 med

+7995% premium

P/S vs peers

73.10 / 3.54 med

+1966% premium

Net margin vs peers

5.4% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.